Podcasts Technology Law Bytes Episode 46: Matthew Herder on the Canadian Effort to Break Down Patent Barriers to Accessing Coronavirus Medicines

Episode 46: Matthew Herder on the Canadian Effort to Break Down Patent Barriers to Accessing Coronavirus Medicines

Published: Oct. 28, 2021, 6:26 p.m.

b'Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government\\u2019s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.\\nThe podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.\\n\\nCredits:\\nCTV News, Canada\\u2019s Chief Public Health Officer Says a Coronavirus Vaccine is \\u2018Probably\\u2019 a Year Away'